ResMed Inc. Announces Executive and Board Changes
Ticker: RSMDF · Form: 8-K · Filed: Aug 16, 2024 · CIK: 943819
| Field | Detail |
|---|---|
| Company | Resmed Inc (RSMDF) |
| Form Type | 8-K |
| Filed Date | Aug 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.004 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
ResMed shakes up exec team & board on Aug 15th.
AI Summary
ResMed Inc. announced on August 15, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key executives. Specific details regarding the individuals involved and the exact nature of the compensatory changes are outlined within the report.
Why It Matters
Changes in executive leadership and board composition can signal shifts in company strategy, governance, or future performance, impacting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- ResMed Inc. (company) — Registrant
- August 15, 2024 (date) — Date of earliest event reported
- 9001 Spectrum Center Blvd. San Diego , California 92123 (address) — Principal Executive Offices
- 001-15317 (company) — Commission File Number
FAQ
What specific roles have been affected by the departures and appointments?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers,' suggesting shifts across leadership and board positions, though specific names and roles are detailed within the full document.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this Form 8-K filing was on August 15, 2024.
What is ResMed Inc.'s principal executive office address?
ResMed Inc.'s principal executive offices are located at 9001 Spectrum Center Blvd., San Diego, California 92123.
What is the Commission File Number for ResMed Inc.?
The Commission File Number for ResMed Inc. is 001-15317.
What is the SIC code for ResMed Inc.?
The Standard Industrial Classification (SIC) code for ResMed Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 684 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2024-08-16 17:21:58
Key Financial Figures
- $0.004 — nge on which registered Common Stock, $0.004 par value RMD NYSE Indicate by che
Filing Documents
- d885393d8k.htm (8-K) — 27KB
- d885393dex991.htm (EX-99.1) — 8KB
- g885393g0816190155461.jpg (GRAPHIC) — 2KB
- g885393g0816190424921.jpg (GRAPHIC) — 2KB
- 0001193125-24-202204.txt ( ) — 165KB
- rmd-20240815.xsd (EX-101.SCH) — 3KB
- rmd-20240815_lab.xml (EX-101.LAB) — 18KB
- rmd-20240815_pre.xml (EX-101.PRE) — 11KB
- d885393d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. Date: August 16, 2024 RESMED INC. (registrant) By: /s/ Michael Rider Name: Michael Rider Its: Secretary -4-